Dose Response Study of VA106483 in Males With Nocturia and Benign Prostatic Hypertrophy (BPH)
Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to establish the dose response relationship of VA106483 and
nocturnal urine volumes in a population of elderly male subjects with Benign Prostatic
Hypertrophy (BPH) who are likely to present with nocturia.